Therapeutic apheresis: Results from a single center in Turkey

Transfusion and Apheresis Science

Volumn 36, Issue 3, 2007, Pages 249-253

  Yavasoglu, Irfan ^a   Kadikoylu, Gurhan ^a   Akyol, Ali ^a   Bolaman, Zahit ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Adverse events; Leukapheresis; Plasma exchange; Therapeutic apheresis; Therapeutic plateletpheresis

Indexed keywords

HEMOGLOBIN;

ABDOMINAL PAIN; ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; LEUKAPHERESIS; MALE; NAUSEA; PLASMAPHERESIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOPHERESIS; TURKEY (REPUBLIC); VOMITING;

ADULT; AGED; BLOOD COMPONENT REMOVAL; FEMALE; HEMOGLOBINS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; PLASMA EXCHANGE; PLATELET COUNT; PLATELETPHERESIS; RETROSPECTIVE STUDIES; TURKEY;

EID: 34547109104     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.02.002     Document Type: Article

References (30)

1. Jones H.G., and Bandarenko N. Management of the therapeutic apheresis patient. In: McLeod B., Price T.H., and Weinstein R. (Eds). Apheresis, Principles and Practice. 2nd ed. (2003), American Association of Blood Banks Press, Maryland 253-274
2. Shehata N., Kouroukis C., and Kelton J.G. A review of randomized controlled trials using therapeutic apheresis. Transfus Med Rev 16 (2002) 200-229
3. Arslan O., Arat M., Gokturk S., Ayyildiz E., and Ilhan O. Therapeutic plasma exchange and the clinical applications. Turk J Haematol 20 (2003) 7-17
4. Smith JW, Weinstein R, Hillyer KL. Therapeutic aphersis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 43:820-22.
5. Ilhan O., Uskent N., Arslan O., Arat M., Ozkalemkas F., Ozturk G., et al. National survey of hemapheresis practice in Turkey (1998). Transfus Apher Sci 22 (2000) 195-201
6. Rock G.A., Herbert C.A., and Canadian Apheresis Group. Therapeutic apheresis in Canada. J Clin Apheresis 7 (1992) 47-48
7. Korach J.M., Bussel A., and Gajdos P. The national survey of plasma exchange and therapeutic cytapheresis in France. Transfus Sci 16 (1995) 363-370
8. Narciso C.T. Therapeutic apheresis in the Philippines. Transfus Apher Sci 33 (2005) 3-9
9. Moog R. Haemapheresis activities in Germany. Transfus Apher Sci 32 (2005) 283-286
10. Norda R., Stegmayr B.G., and The Swedish Apheresis Group. Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci 29 (2003) 159-166
11. Passalacqua S., Staffolani E., Busnach G., Roccatello D., Pasquali P., and Liuzzo G. The Italian registry for therapeutic apheresis. A report from the apheresis study group of the Italian Society of Nephrology. J Clin Apher 20 (2005) 101-106
12. Saltiel C. Apheresis activity in Venezuella. J Clin Apher 20 (2005) 95-100
13. Taraldsrud E., Kvalheim G., Jorstad S., Stavem K., and Aandahl G.S. A survey of therapeutic hemapheresis in Norway year 2000. Transfus Apher Sci 28 (2003) 135-141
14. Korach J.M., Petitpas D., Paris B., Bourgeade F., Passerat V., Berger Ph., et al., French Registry Group. Plasma exchange in France: epidemiology 2001. Transfus Apher Sci 29 (2003) 153-157
15. Valbonesi M., Bruni R., and De Luigi M.C. Therapeutic hemapheresis as of 2000. Vox Sang 78 suppl 2 (2000) 51-56
16. Rock G., Clark B., and Sutton D. The Canadian apheresis registry. Transfus Apher Sci 29 (2003) 167-177
17. Malchesky P.S., Koo A.P., Roberson G.A., Hadsell A.T., and Rybicki L.A. Apheresis technologies and clinical applications: The 2002 International Apheresis Registry. Ther Apher Dial 8 (2004) 124-143
18. De Silvestro G., Marson P., Russo G.E., Vicarioto M., and Donadel C. National survey of apheresis activity in Italy 2000. Transfus Apher Sci 30 (2004) 61-71
19. Grima K.M. Therapeutic apheresis in hematological and oncological diseases. J Clin Apher 15 (2000) 28-52
20. Hester J. Therapeutic cell depletion. In: McLeod B., Price T.H., and Weinstein R. (Eds). Apheresis, Principles and Practice. 2nd ed. (2003), American Association of Blood Banks Press, Maryland 283-294
21. Strobl F.J., Voelkerding K.V., and Smith E.P. Management of chronic myeloid leukemia during pregnancy with leukapheresis. J Clin Apher 14 (1999) 42-44
22. Porcu P., Farag S., Marcucci G., Cataland S.R., Kennedy M.S., and Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 6 (2002) 15-23
23. Giles F.J., Shen Y., Kantarjian H.M., Korbling M.J., O'Brien S., Anderlini P., et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leukemia Lymphoma 42 (2001) 67-73
24. Huestis D.W., Price M.J., White R.F., and Inman M. Leukapheresis of patients with chronic granulocytic leukemia using the Haemonetics blood precursor. Transfusion 16 (1976) 255-259
25. Sleeper T., Smith J., and McCullough J. Therapeutic cytapheresis using the Fenwal CS3000 blood cell separator. Vox Sang 48 (1985) 193-200
26. Yavasoglu I., Kadikoylu G., and Bolaman Z. Recovery of splenic infarction with anti-platelet treatments and platelet-apheresis in polycythemia vera. Transfus Apher Sci 34 (2006) 199-202
27. Liumbruno G., Centoni P.E., Ceretelli S., and Sodini M.L. Rapid reduction of platelet numbers in thrombocytosis. Ther Apher 4 (2000) 374-376
28. Wood L., and Jacops P. The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin and complement levels. J Clin Apher 3 (1986) 124-128
29. Schroeder M.L. Principle and practice of transfusion medicine. In: Lee G.R., Foerster J., Lukens J., Paraskevas F., Greer J.P., and Rodgers G.M. (Eds). Wintrobe's Cinical Hematology. 10th ed. (1999), Williams-Wilkins, Baltimore 817-874
30. Sutton D.M.C., Nair R.C., Rock G., and The Canadian Apheresis Study Group. Complicatons of plasma exchange. Transfusion 29 (1989) 124-127